Bokf Na Sells 20,157 Shares of Corteva, Inc. $CTVA

Bokf Na lowered its position in shares of Corteva, Inc. (NYSE:CTVA) by 16.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 101,513 shares of the company’s stock after selling 20,157 shares during the quarter. Bokf Na’s holdings in Corteva were worth $6,865,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Total Investment Management Inc. bought a new position in Corteva during the second quarter worth about $27,000. Activest Wealth Management raised its stake in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares in the last quarter. True Wealth Design LLC boosted its holdings in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the period. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva in the 2nd quarter valued at about $29,000. Finally, Redmont Wealth Advisors LLC acquired a new position in shares of Corteva during the 3rd quarter worth approximately $29,000. Institutional investors own 81.54% of the company’s stock.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.14% of the stock is owned by company insiders.

Corteva Stock Performance

NYSE CTVA opened at $79.76 on Friday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $53.64 billion, a price-to-earnings ratio of 50.48, a P/E/G ratio of 2.69 and a beta of 0.72. The firm’s 50 day simple moving average is $73.88 and its 200 day simple moving average is $69.20. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.90.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same period in the previous year, the business earned $0.32 earnings per share. The company’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CTVA. Mizuho lifted their price target on shares of Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a research report on Tuesday, February 17th. CICC Research increased their price target on Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. The Goldman Sachs Group restated a “buy” rating and set a $88.00 price objective on shares of Corteva in a research note on Thursday, February 5th. UBS Group cut Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Finally, Jefferies Financial Group increased their target price on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average target price of $82.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.